BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Matsushita K, Sang Y, Ballew SH, Shlipak M, Katz R, Rosas SE, Peralta CA, Woodward M, Kramer HJ, Jacobs DR, Sarnak MJ, Coresh J. Subclinical atherosclerosis measures for cardiovascular prediction in CKD. J Am Soc Nephrol 2015;26:439-47. [PMID: 25145930 DOI: 10.1681/ASN.2014020173] [Cited by in Crossref: 73] [Cited by in F6Publishing: 36] [Article Influence: 9.1] [Reference Citation Analysis]
Number Citing Articles
1 Liabeuf S, Desjardins L, Diouf M, Temmar M, Renard C, Choukroun G, Massy ZA. The Addition of Vascular Calcification Scores to Traditional Risk Factors Improves Cardiovascular Risk Assessment in Patients with Chronic Kidney Disease. PLoS One. 2015;10:e0131707. [PMID: 26181592 DOI: 10.1371/journal.pone.0131707] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 3.7] [Reference Citation Analysis]
2 Gorriz JL, Arroyo D, D'Marco L, Torra R, Tomás P, Puchades MJ, Panizo N, Pantoja J, Montomoli M, Llisterri JL, Pallares-Carratalá V, Valdivielso JM. Cardiovascular risk factors and the impact on prognosis in patients with chronic kidney disease secondary to autosomal dominant polycystic kidney disease. BMC Nephrol 2021;22:110. [PMID: 33765945 DOI: 10.1186/s12882-021-02313-1] [Reference Citation Analysis]
3 Sun J, Axelsson J, Machowska A, Heimbürger O, Bárány P, Lindholm B, Lindström K, Stenvinkel P, Qureshi AR. Biomarkers of Cardiovascular Disease and Mortality Risk in Patients with Advanced CKD. Clin J Am Soc Nephrol 2016;11:1163-72. [PMID: 27281698 DOI: 10.2215/CJN.10441015] [Cited by in Crossref: 72] [Cited by in F6Publishing: 42] [Article Influence: 12.0] [Reference Citation Analysis]
4 Pang CL, Pilkington N, Wei Y, Peters J, Roobottom C, Hyde C. A methodology review on the incremental prognostic value of computed tomography biomarkers in addition to Framingham risk score in predicting cardiovascular disease: the use of association, discrimination and reclassification. BMC Cardiovasc Disord 2018;18:39. [PMID: 29466951 DOI: 10.1186/s12872-018-0777-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
5 Bover J, Aguilar A, Arana C, Molina P, Lloret MJ, Ochoa J, Berná G, Gutiérrez-Maza YG, Rodrigues N, D'Marco L, Górriz JL. Clinical Approach to Vascular Calcification in Patients With Non-dialysis Dependent Chronic Kidney Disease: Mineral-Bone Disorder-Related Aspects. Front Med (Lausanne) 2021;8:642718. [PMID: 34095165 DOI: 10.3389/fmed.2021.642718] [Reference Citation Analysis]
6 Charoen P, Nitsch D, Engmann J, Shah T, White J, Zabaneh D, Jefferis B, Wannamethee G, Whincup P, Mulick Cassidy A, Gaunt T, Day I, McLachlan S, Price J, Kumari M, Kivimaki M, Brunner E, Langenberg C, Ben-Shlomo Y, Hingorani A, Whittaker J, Pablo Casas J, Dudbridge F; UCLEB Consortium. Mendelian Randomisation study of the influence of eGFR on coronary heart disease. Sci Rep 2016;6:28514. [PMID: 27338949 DOI: 10.1038/srep28514] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
7 Kouis P, Kousios A, Kanari A, Kleopa D, Papatheodorou SI, Panayiotou AG. Association of non-invasive measures of subclinical atherosclerosis and arterial stiffness with mortality and major cardiovascular events in chronic kidney disease: systematic review and meta-analysis of cohort studies. Clin Kidney J 2020;13:842-54. [PMID: 33542824 DOI: 10.1093/ckj/sfz095] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
8 Han H, Zhu J, Zhu Z, Ni J, Du R, Dai Y, Chen Y, Wu Z, Lu L, Zhang R. p-Cresyl sulfate aggravates cardiac dysfunction associated with chronic kidney disease by enhancing apoptosis of cardiomyocytes. J Am Heart Assoc 2015;4:e001852. [PMID: 26066032 DOI: 10.1161/JAHA.115.001852] [Cited by in Crossref: 52] [Cited by in F6Publishing: 35] [Article Influence: 7.4] [Reference Citation Analysis]
9 Hruska KA, Seifert M, Sugatani T. Pathophysiology of the chronic kidney disease-mineral bone disorder. Curr Opin Nephrol Hypertens 2015;24:303-9. [PMID: 26050115 DOI: 10.1097/MNH.0000000000000132] [Cited by in Crossref: 10] [Cited by in F6Publishing: 24] [Article Influence: 1.7] [Reference Citation Analysis]
10 Agapova OA, Fang Y, Sugatani T, Seifert ME, Hruska KA. Ligand trap for the activin type IIA receptor protects against vascular disease and renal fibrosis in mice with chronic kidney disease. Kidney Int 2016;89:1231-43. [PMID: 27165838 DOI: 10.1016/j.kint.2016.02.002] [Cited by in Crossref: 47] [Cited by in F6Publishing: 41] [Article Influence: 7.8] [Reference Citation Analysis]
11 Visseren FLJ, Mach F, Smulders YM, Carballo D, Koskinas KC, Bäck M, Benetos A, Biffi A, Boavida JM, Capodanno D, Cosyns B, Crawford C, Davos CH, Desormais I, Di Angelantonio E, Franco OH, Halvorsen S, Hobbs FDR, Hollander M, Jankowska EA, Michal M, Sacco S, Sattar N, Tokgozoglu L, Tonstad S, Tsioufis KP, van Dis I, van Gelder IC, Wanner C, Williams B; ESC Scientific Document Group . 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice. Eur J Prev Cardiol 2021:zwab154. [PMID: 34558602 DOI: 10.1093/eurjpc/zwab154] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
12 Bellasi A, Raggi P, Bover J, Bushinsky DA, Chertow GM, Ketteler M, Rodriguez M, Sinha S, Salcedo C, Garg R, Gold A, Perelló J. Trial design and baseline characteristics of CaLIPSO: a randomized, double-blind placebo-controlled trial of SNF472 in patients receiving haemodialysis with cardiovascular calcification. Clin Kidney J 2021;14:366-74. [PMID: 33564440 DOI: 10.1093/ckj/sfz144] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
13 Bjergfelt SS, Sørensen IMH, Hjortkjær HØ, Landler N, Ballegaard ELF, Biering-Sørensen T, Kofoed KF, Lange T, Feldt-Rasmussen B, Sillesen H, Christoffersen C, Bro S. Carotid plaque thickness is increased in chronic kidney disease and associated with carotid and coronary calcification. PLoS One 2021;16:e0260417. [PMID: 34813630 DOI: 10.1371/journal.pone.0260417] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Becherucci F, Roperto RM, Materassi M, Romagnani P. Chronic kidney disease in children. Clin Kidney J 2016;9:583-91. [PMID: 27478602 DOI: 10.1093/ckj/sfw047] [Cited by in Crossref: 70] [Cited by in F6Publishing: 51] [Article Influence: 11.7] [Reference Citation Analysis]
15 Kousios A, Kouis P, Panayiotou AG. Matrix Metalloproteinases and Subclinical Atherosclerosis in Chronic Kidney Disease: A Systematic Review. Int J Nephrol. 2016;2016:9498013. [PMID: 27042350 DOI: 10.1155/2016/9498013] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
16 Wu P, Glerup RI, Svensson MHS, Eriksson N, Christensen JH, Laval PD, Soveri I, Westerlund M, Linde T, Ljunggren Ö, Fellström B. Novel Biomarkers Detected by Proteomics Predict Death and Cardiovascular Events in Hemodialysis Patients. Biomedicines 2022;10:740. [DOI: 10.3390/biomedicines10040740] [Reference Citation Analysis]
17 L.j. Visseren F, Mach F, M. Smulders Y, Carballo D, C. Koskinas K, Bäck M, Benetos A, Biffi A, Manuel Boavida J, Capodanno D, Cosyns B, Crawford C, H. Davos C, Desormais I, Di Angelantonio E, H. Franco O, Halvorsen S, Richard Hobbs F, Hollander M, A. Jankowska E, Michal M, Sacco S, Sattar N, Tokgozoglu L, Tonstad S, P. Tsioufis K, van Dis I, C. van Gelder I, Wanner C, Williams B. Guía ESC 2021 sobre la prevención de la enfermedad cardiovascular en la práctica clínica. Revista Española de Cardiología 2022. [DOI: 10.1016/j.recesp.2021.10.016] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Sakaguchi Y, Hamano T, Nakano C, Obi Y, Matsui I, Kusunoki Y, Mori D, Oka T, Hashimoto N, Takabatake Y, Takahashi A, Kaimori JY, Moriyama T, Yamamoto R, Horio M, Sugimoto K, Yamamoto K, Rakugi H, Isaka Y. Association between Density of Coronary Artery Calcification and Serum Magnesium Levels among Patients with Chronic Kidney Disease. PLoS One 2016;11:e0163673. [PMID: 27662624 DOI: 10.1371/journal.pone.0163673] [Cited by in Crossref: 33] [Cited by in F6Publishing: 23] [Article Influence: 5.5] [Reference Citation Analysis]
19 Provenzano M, Andreucci M, Garofalo C, Faga T, Michael A, Ielapi N, Grande R, Sapienza P, Franciscis S, Mastroroberto P, Serra R. The Association of Matrix Metalloproteinases with Chronic Kidney Disease and Peripheral Vascular Disease: A Light at the End of the Tunnel? Biomolecules 2020;10:E154. [PMID: 31963569 DOI: 10.3390/biom10010154] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 13.0] [Reference Citation Analysis]
20 Bundy JD, Rahman M, Matsushita K, Jaeger BC, Cohen JB, Chen J, Deo R, Dobre MA, Feldman HI, Flack J, Kallem RR, Lash JP, Seliger S, Shafi T, Weiner SJ, Wolf M, Yang W, Allen NB, Bansal N, He J; CRIC Study Investigators. Risk Prediction Models for Atherosclerotic Cardiovascular Disease in Patients with Chronic Kidney Disease: The CRIC Study. J Am Soc Nephrol 2022:ASN. [PMID: 35145041 DOI: 10.1681/ASN.2021060747] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
21 Matsushita K, Ballew SH, Coresh J. Cardiovascular risk prediction in people with chronic kidney disease. Curr Opin Nephrol Hypertens 2016;25:518-23. [PMID: 27517136 DOI: 10.1097/MNH.0000000000000265] [Cited by in Crossref: 19] [Cited by in F6Publishing: 7] [Article Influence: 4.8] [Reference Citation Analysis]
22 Zhang T, Yin H, Xue H. Evaluation of ultrasonography on carotid arteries and left ventricular function in patients with subclinical atherosclerosis. Exp Ther Med 2019;17:4465-70. [PMID: 31105784 DOI: 10.3892/etm.2019.7517] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
23 Bressendorff I, Hansen D, Schou M, Kragelund C, Brandi L. The effect of magnesium supplementation on vascular calcification in chronic kidney disease-a randomised clinical trial (MAGiCAL-CKD): essential study design and rationale. BMJ Open 2017;7:e016795. [PMID: 28645983 DOI: 10.1136/bmjopen-2017-016795] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 5.0] [Reference Citation Analysis]
24 Anis KH, Pober D, Rosas SE. Vitamin D Analogues and Coronary Calcification in CKD Stages 3 and 4: A Randomized Controlled Trial of Calcitriol Versus Paricalcitol. Kidney Med 2020;2:450-8. [PMID: 32775985 DOI: 10.1016/j.xkme.2020.05.009] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
25 Colbert G, Jain N, de Lemos JA, Hedayati SS. Utility of traditional circulating and imaging-based cardiac biomarkers in patients with predialysis CKD. Clin J Am Soc Nephrol 2015;10:515-29. [PMID: 25403922 DOI: 10.2215/CJN.03600414] [Cited by in Crossref: 33] [Cited by in F6Publishing: 13] [Article Influence: 4.1] [Reference Citation Analysis]
26 Kousios A, Kouis P, Hadjivasilis A, Panayiotou A. Cardiovascular Risk Assessment Using Ultrasonographic Surrogate Markers of Atherosclerosis and Arterial Stiffness in Patients With Chronic Renal Impairment: A Narrative Review of the Evidence and a Critical View of Their Utility in Clinical Practice. Can J Kidney Health Dis 2020;7:2054358120954939. [PMID: 32963791 DOI: 10.1177/2054358120954939] [Reference Citation Analysis]
27 Ruiz JL, Weinbaum S, Aikawa E, Hutcheson JD. Zooming in on the genesis of atherosclerotic plaque microcalcifications. J Physiol 2016;594:2915-27. [PMID: 27040360 DOI: 10.1113/JP271339] [Cited by in Crossref: 21] [Cited by in F6Publishing: 10] [Article Influence: 3.5] [Reference Citation Analysis]
28 Sakaguchi Y, Hamano T, Isaka Y. Effects of Magnesium on the Phosphate Toxicity in Chronic Kidney Disease: Time for Intervention Studies. Nutrients 2017;9:E112. [PMID: 28178182 DOI: 10.3390/nu9020112] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 4.6] [Reference Citation Analysis]
29 Hruska KA, Sugatani T, Agapova O, Fang Y. The chronic kidney disease - Mineral bone disorder (CKD-MBD): Advances in pathophysiology. Bone 2017;100:80-6. [PMID: 28119179 DOI: 10.1016/j.bone.2017.01.023] [Cited by in Crossref: 73] [Cited by in F6Publishing: 58] [Article Influence: 14.6] [Reference Citation Analysis]
30 Kim H, Yoo TH, Choi KH, Oh KH, Lee J, Kim SW, Kim TH, Sung S, Han SH; KNOW-CKD Group. Baseline Cardiovascular Characteristics of Adult Patients with Chronic Kidney Disease from the KoreaN Cohort Study for Outcomes in Patients With Chronic Kidney Disease (KNOW-CKD). J Korean Med Sci 2017;32:231-9. [PMID: 28049233 DOI: 10.3346/jkms.2017.32.2.231] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.2] [Reference Citation Analysis]
31 Chen J, Budoff MJ, Reilly MP, Yang W, Rosas SE, Rahman M, Zhang X, Roy JA, Lustigova E, Nessel L, Ford V, Raj D, Porter AC, Soliman EZ, Wright JT Jr, Wolf M, He J; CRIC Investigators. Coronary Artery Calcification and Risk of Cardiovascular Disease and Death Among Patients With Chronic Kidney Disease. JAMA Cardiol 2017;2:635-43. [PMID: 28329057 DOI: 10.1001/jamacardio.2017.0363] [Cited by in Crossref: 113] [Cited by in F6Publishing: 100] [Article Influence: 37.7] [Reference Citation Analysis]
32 Papageorgiou N, Briasoulis A, Androulakis E, Tousoulis D. Imaging Subclinical Atherosclerosis: Where Do We Stand? Curr Cardiol Rev 2017;13:47-55. [PMID: 27492229 DOI: 10.2174/1573403x12666160803095855] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 1.6] [Reference Citation Analysis]
33 Cano-Megías M, Guisado-Vasco P, Bouarich H, de Arriba-de la Fuente G, de Sequera-Ortiz P, Álvarez-Sanz C, Rodríguez-Puyol D. Coronary calcification as a predictor of cardiovascular mortality in advanced chronic kidney disease: a prospective long-term follow-up study. BMC Nephrol 2019;20:188. [PMID: 31138150 DOI: 10.1186/s12882-019-1367-1] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 7.3] [Reference Citation Analysis]
34 Bellasi A, Di Lullo L, Russo D, Ciarcia R, Magnocavallo M, Lavalle C, Ratti C, Cozzolino M, Di Iorio BR. Vascular Calcification Progression Modulates the Risk Associated with Vascular Calcification Burden in Incident to Dialysis Patients. Cells 2021;10:1091. [PMID: 34063597 DOI: 10.3390/cells10051091] [Reference Citation Analysis]
35 Provenzano M, Andreucci M, De Nicola L, Garofalo C, Battaglia Y, Borrelli S, Gagliardi I, Faga T, Michael A, Mastroroberto P, Serraino GF, Licastro N, Ielapi N, Serra R. The Role of Prognostic and Predictive Biomarkers for Assessing Cardiovascular Risk in Chronic Kidney Disease Patients. Biomed Res Int 2020;2020:2314128. [PMID: 33102575 DOI: 10.1155/2020/2314128] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
36 Suh-Chiou C, Moysés RM, Bittencourt MS, Bensenor IM, Lotufo PA. Chronic kidney disease and coronary artery calcification in the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil). Clin Cardiol 2017;40:1309-15. [PMID: 29243272 DOI: 10.1002/clc.22829] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
37 Al Sayed N, Almahmeed W, Alnouri F, Al Waili K, Sabbour H, Sulaiman K, Zubaid M, Ray KK, Al-rasadi K. Consensus clinical recommendations for the management of plasma lipid disorders in the Middle East – 2021 update. Atherosclerosis 2021. [DOI: 10.1016/j.atherosclerosis.2021.11.022] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
38 Nelson AJ, Raggi P, Wolf M, Gold AM, Chertow GM, Roe MT. Targeting Vascular Calcification in Chronic Kidney Disease. JACC Basic Transl Sci 2020;5:398-412. [PMID: 32368697 DOI: 10.1016/j.jacbts.2020.02.002] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 11.5] [Reference Citation Analysis]
39 Lees JS, Mangion K, Rutherford E, Witham MD, Woodward R, Roditi G, Hopkins T, Brooksbank K, Jardine AG, Mark PB. Vitamin K for kidney transplant organ recipients: investigating vessel stiffness (ViKTORIES): study rationale and protocol of a randomised controlled trial. Open Heart 2020;7:e001070. [PMID: 32675297 DOI: 10.1136/openhrt-2019-001070] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
40 Sørensen IMH, Saurbrey SAK, Hjortkjær HØ, Brainin P, Carlson N, Ballegaard ELF, Kamper AL, Christoffersen C, Feldt-Rasmussen B, Kofoed KF, Bro S. Regional distribution and severity of arterial calcification in patients with chronic kidney disease stages 1-5: a cross-sectional study of the Copenhagen chronic kidney disease cohort. BMC Nephrol 2020;21:534. [PMID: 33297991 DOI: 10.1186/s12882-020-02192-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
41 Lee MJ, Park JT, Chang TI, Joo YS, Yoo TH, Park SK, Chung W, Kim YS, Kim SW, Oh KH, Kang SW, Choi KH, Ahn C, Han SH. Smoking Cessation and Coronary Artery Calcification in CKD. Clin J Am Soc Nephrol 2021;16:870-9. [PMID: 33879501 DOI: 10.2215/CJN.15751020] [Reference Citation Analysis]
42 Visseren FLJ, Mach F, Smulders YM, Carballo D, Koskinas KC, Bäck M, Benetos A, Biffi A, Boavida JM, Capodanno D, Cosyns B, Crawford C, Davos CH, Desormais I, Di Angelantonio E, Franco OH, Halvorsen S, Hobbs FDR, Hollander M, Jankowska EA, Michal M, Sacco S, Sattar N, Tokgozoglu L, Tonstad S, Tsioufis KP, van Dis I, van Gelder IC, Wanner C, Williams B; ESC National Cardiac Societies., ESC Scientific Document Group. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J 2021;42:3227-337. [PMID: 34458905 DOI: 10.1093/eurheartj/ehab484] [Cited by in Crossref: 76] [Cited by in F6Publishing: 26] [Article Influence: 76.0] [Reference Citation Analysis]
43 Sakaguchi Y, Hamano T, Obi Y, Monden C, Oka T, Yamaguchi S, Matsui I, Hashimoto N, Matsumoto A, Shimada K, Takabatake Y, Takahashi A, Kaimori JY, Moriyama T, Yamamoto R, Horio M, Yamamoto K, Sugimoto K, Rakugi H, Isaka Y. A Randomized Trial of Magnesium Oxide and Oral Carbon Adsorbent for Coronary Artery Calcification in Predialysis CKD. J Am Soc Nephrol 2019;30:1073-85. [PMID: 31036759 DOI: 10.1681/ASN.2018111150] [Cited by in Crossref: 46] [Cited by in F6Publishing: 31] [Article Influence: 15.3] [Reference Citation Analysis]